Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes

Archives of Dermatological Research

Volumn 304, Issue 1, 2012, Pages 47-55

  Passero, Luiz Felipe Domingues ^a   Marques, Cláudia ^b   Vale Gato, Inês ^b   Corbett, Carlos Eduardo Pereira ^a   Laurenti, Márcia Dalastra ^a   Santos Gomes, Gabriela ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Immune response; Immunization; Leishmania shawi; Released antigens

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LEISHMANIA VACCINE; MESSENGER RNA; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; IMMUNIZATION; IMMUNOASSAY; LEISHMANIA; LEISHMANIA SHAWI; LEISHMANIASIS; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIGENS, PROTOZOAN; CELLS, CULTURED; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; IMMUNIZATION; IMMUNOLOGIC MEMORY; LEISHMANIA; LEISHMANIASIS VACCINES; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; TH1-TH2 BALANCE;

EID: 84857055053     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1171-7     Document Type: Article

References (43)

1. C Bogdan 2008 Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example Cell Microbiol 10 1221 1234 18363880 10.1111/j.1462-5822.2008.01146.x 1:CAS:528:DC%2BD1cXntlWksb8%3D (Pubitemid 351663916)
2. ME Brito MS Andrade MG Mendonça CJ Silva EL Almeida BS Lima SM Félix FG Abath GC da Graça R Porrozzi EA Ishikawa JJ Shaw E Cupolillo SP Brandão-Filho 2009 Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil Trop Med Int Health 14 1278 1286 19708899 10.1111/j.1365-3156.2009.02361.x 1:CAS:528:DC%2BD1MXht12hu7rN
3. FP Carneiro AV De Magalhães M De Jesus Abreu Almeida Couto AL Bocca MI Muniz-Junqueira RN Ribeiro Sampaio 2009 Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis Parasite Immunol 31 646 651 19751477 10.1111/j.1365-3024.2009.01148.x 1:CAS:528: DC%2BD1MXht12hu7vM
4. G Chen G Han J Wang R Wang R Xu B Shen J Qian Y Li 2009 Natural killer cells modulate overt autoimmunity to homeostasis in nonobese diabetic mice after anti-CD3 F(ab')2 antibody treatment through secreting transforming growth factor-beta Am J Pathol 175 1086 1094 19644014 10.2353/ajpath.2009.080488 1:CAS:528:DC%2BD1MXhtF2isb3P
5. PA Darrah ST Hegde DT Patel RW Lindsay L Chen M Roederer RA Seder 2010 IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform J Exp Med 207 1421 1433 20530206 10.1084/jem.20092532 1:CAS:528:DC%2BC3cXovFaktLg%3D
6. O Dunning 2009 Leishmania vaccines: from leishmanization to the era of DNA technology Biosci Horiz 2 73 82 10.1093/biohorizons/hzp004 1:CAS:528:DC%2BD1MXjsl2qsLc%3D
7. CM Filippi AE Juedes JE Oldham E Ling L Togher Y Peng RA Flavell MG von Herrath 2008 Transforming growth factor-beta suppresses the activation of CD8 + T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity Diabetes 57 2684 2692 18689691 10.2337/db08-0609 1:CAS:528:DC%2BD1MXhs1Kntr8%3D
8. C Ivory K Chadee 2004 DNA vaccines: designing strategies against parasitic infections Genet Vaccin Ther 2 17 10.1186/1479-0556-2-17 (Pubitemid 40471993)
9. JS Kang C Liu R Derynck 2009 New regulatory mechanisms of TGF-beta receptor function Trends Cell Biol 19 385 394 19648010 10.1016/j.tcb.2009.05.008 1:CAS:528:DC%2BD1MXhtVSitLjF
10. SH Kaufmann J Hess 1999 Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development Immunol Lett 65 81 94 10065631 10.1016/S0165-2478(98)00128-X 1:CAS:528: DyaK1MXksFGiuw%3D%3D (Pubitemid 29074504)
11. RD Kreutzer A Corredor G Grimaldi Jr M Grogl ED Rowton DG Young A Morales D McMahon-Pratt H Guzman RB Tesh 1991 Characterization of Leishmania colombiensis sp. n (Kinetoplastida: Trypanosomatidae), a new parasite infecting humans, animals, and phlebotomine sand flies in Colombia and Panama Am J Trop Med Hyg 44 662 675 1677544 1:STN:280:DyaK3MzhsVymsw%3D%3D
12. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 5432063 10.1038/227680a0 1:CAS:528:DC%2BD3MXlsFags7s%3D
13. R Lainson RR Braga AA De Souza MM Pôvoa EA Ishikawa FT Silveira 1989 Leishmania (Viannia) shawi sp. n., a parasite of monkeys, sloths and procyonids in Amazonian, Brazil Ann Parasitol Hum Comp 64 200 207 2504099 1:STN:280:DyaL1MzkvF2rtg%3D%3D
14. R Lainson JJ Shaw 1989 Leishmania (Viannia) naiffi sp. n., a parasite of the armadillo, Dasypus novemcinctus (L.) in Amazonian, Brazil Ann Parasitol Hum Comp 64 3 9 2930120 1:STN:280:DyaL1M7pt1SltA%3D%3D
15. JL Lemesre P Holzmuller M Cavaleyra RB Gonçalves G Hottin G Papierok 2005 Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes Vaccine 23 2825 2840 15780731 10.1016/j.vaccine.2004.11. 061 1:CAS:528:DC%2BD2MXisVWkt7o%3D (Pubitemid 40386484)
16. JL Lemesre P Holzmuller RB Gonçalves G Bourdoiseau C Hugnet M Cavaleyra G Papierok 2007 Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial Vaccine 25 4223 4234 17395339 10.1016/j.vaccine.2007.02.083 1:CAS:528:DC%2BD2sXkslWqs7s%3D (Pubitemid 46661824)
17. FY Liew Y Li S Millott 1990 Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide J Immunol 145 4306 4310 2175327 1:CAS:528:DyaK3MXmtVagsQ%3D%3D
18. R Nagill R Mahajan M Sharma S Kaur 2009 Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis Parasitol Int 58 359 366 19638322 10.1016/j.parint.2009.07.008 1:CAS:528:DC%2BD1MXht1CmtbbE
19. S Naundorf M Schröder C Höflich N Suman HD Volk G Grütz 2009 IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells Eur J Immunol 39 1066 1077 19266486 10.1002/eji.200838773 1:CAS:528:DC%2BD1MXltlamu7o%3D
20. R Novoa O Bacellar M Nascimento TM Cardoso R Ramasawmy WN Oliveira A Schriefer EM Carvalho 2011 IL-17 and regulatory cytokines (IL-10 and IL-27) in L. braziliensis infection Parasite Immunol 33 132 136 21226726 10.1111/j.1365-3024.2010.01256.x 1:CAS:528:DC%2BC3MXisF2gt7w%3D
21. I Okwor J Uzonna 2008 Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies Immunol Res 41 123 136 18389179 10.1007/s12026-008-8016-2
22. JA O'Daly R Lezama PJ Rodriguez E Silva NR Indriago G Peña I Colorado J Gleason B Rodríguez L Acuña T Ovalles 2009 Antigens from Leishmania amastigotes induced clinical remission of psoriasis Arch Dermatol Res 301 1 13 18777031 10.1007/s00403-008-0883-9
23. JA O'Daly R Lezama J Gleason 2009 Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis Arch Dermatol Res 301 411 427 19294395 10.1007/s00403-009-0940-z
24. JA O'Daly B Rodriguez T Ovalles C Pelaez 2010 Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with Leishmania antigens Arch Dermatol Res 302 95 104 19707779 10.1007/s00403-009- 0992-0
25. JA O'Daly JP Gleason G Peña I Colorado 2010 Purified proteins from Leishmania amastigotes-induced delayed type hypersensitivity reactions and remission of collagen-induced arthritis in animal models Arch Dermatol Res 302 567 581 20063004 10.1007/s00403-009-1026-7
26. JA O'Daly J Gleason R Lezama PJ Rodriguez E Silva NR Indriago 2011 Antigens from Leishmania amastigotes inducing clinical remission of psoriatic arthritis Arch Dermatol Res 303 399 415 21328087 10.1007/s00403-011-1133-0
27. LFD Passero JV Sacomori TY Tomokane CE Corbett FT da Silveira MD Laurenti 2009 Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi Parasitol Res 105 1741 1747 19756748 10.1007/s00436-009-1614-7
28. LFD Passero C Marques I Vale-Gato CEP Corbett MD Laurenti G Santos-Gomes 2010 Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi Parasitol Int 59 159 165 20060062 10.1016/j.parint.2009.12.010 1:CAS:528:DC%2BC3cXlsVOru74%3D
29. LF Passero ML Da Costa Bordon AK De Carvalho LM Martins CE Corbett MD Laurenti 2010 Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms APMIS 118 973 981 21091779 10.1111/j.1600-0463.2010.02679.x 1:CAS:528:DC%2BC3MXjslKntA%3D%3D
30. OR Rodrigues RA Moura S Gomes-Pereira GM Santos-Gomes 2006 H-2 complex influences cytokine gene expression in Leishmania infantum-infected macrophages Cell Immunol 243 118 126 17316586 10.1016/j.cellimm.2007.01.005 1:CAS:528:DC%2BD2sXjsVWhu7o%3D (Pubitemid 46428230)
31. OR Rodrigues C Marques M Soares-Clemente MH Ferronha GM Santos-Gomes 2009 Identification of regulatory T cells during experimental Leishmania infantum infection Immunobiology 214 101 111 19167988 10.1016/j.imbio.2008.07.001 1:CAS:528:DC%2BD1MXivVamt7o%3D
32. A Rodríguez-Cortés A Ojeda L López-Fuertes M Timón L Altet L Solano-Gallego E Sánchez-Robert O Francino J Alberola 2007 Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge Vaccine 25 7962 7971 17942199 10.1016/j.vaccine.2007.08.023 (Pubitemid 47632977)
33. R Rosa OR Rodrigues C Marques GM Santos-Gomes 2005 Leishmania infantum soluble proteins released by the parasite exert differential effects on host immune response Exp Parasitol 109 106 114 15687017 10.1016/j.exppara.2004.11.008 1:CAS:528:DC%2BD2MXptlCktw%3D%3D (Pubitemid 40431335)
34. R Rosa C Marques OR Rodrigues GM Santos-Gomes 2007 Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response Vaccine 25 4525 4532 17478016 10.1016/j.vaccine.2007.04.003 1:CAS:528:DC%2BD2sXlsF2lsrw%3D (Pubitemid 46734540)
35. N Santarém R Silvestre J Tavares M Silva S Cabral J Maciel A Cordeiro-da-Silva 2007 Immune response regulation by Leishmania secreted and nonsecreted antigens J Biomed Biotechnol 6 85154
36. R Shanmugasundaram RK Selvaraj 2010 In vitro human TGF-beta treatment converts CD4(+)CD25(-) T cells into induced T regulatory like cells Vet Immunol Immunopathol 137 161 165 20684851 10.1016/j.vetimm.2010.04.017 1:CAS:528:DC%2BC3cXhtVeksr%2FE
37. JJ Shaw EA Ishikawa R Lainson RR Braga FT Silveira 1991 Cutaneous leishmaniasis of man due to Leishmania (Viannia) shawi Lainson, de Souza, Póvoa, Ishikawa & Silveira, in Pará State, Brazil Ann Parasitol Hum Comp 66 243 246 1822654 1:STN:280:DyaK38zlt1Whtg%3D%3D
38. FT Silveira EA Ishikawa AA De Souza R Lainson 2002 An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region Parasite 9 43 50 11938695 1:STN:280:DC%2BD383gsFymsg%3D%3D (Pubitemid 135699005)
39. FT Silveira R Lainson CE Corbett 2004 Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review Mem Inst Oswaldo Cruz 99 239 241 15273794 10.1590/S0074-02762004000300001
40. C Souza-Lemos SN de-Campos A Teva S Côrte-Real EC Fonseca R Porrozzi G Grimaldi Jr 2008 Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta J Pathol 216 375 386 18702174 10.1002/path.2403 1:STN:280:DC%2BD1cnlvVKnug%3D%3D
41. AW Taylor 2009 Review of the activation of TGF-beta in immunity J Leukoc Biol 85 29 33 18818372 10.1189/jlb.0708415 1:CAS:528:DC%2BD1MXjt1yqug%3D%3D
42. WK Tonui JS Mejia L Hochberg ML Mbow JR Ryan AS Chan SK Martin RG Titus 2004 Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major Infect Immun 72 5654 5661 15385463 10.1128/IAI.72.10.5654-5661.2004 1:CAS:528:DC%2BD2cXotFaltb8%3D (Pubitemid 39303674)
43. J Wolff R Malone P Williams W Chong G Acsadi A Jani PL Felgner 1990 Direct gene transfer into mouse muscle in vivo Science 1247 1465 1468 10.1126/science.1690918